Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long COVID already surpasses that of carpal tunnel, Lyme disease, and psoriasis, the authors said, and is likely to continue to grow.
With lawmakers in Washington, D.C. and state houses getting ready to make major health policy decisions, a pair of new University of Michigan studies shows how past policy decisions have affected older Americans with modest or low incomes.